Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221311 · ClinicalTrials.gov registry record · NA
Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT01221311 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 112 participants.
The verdict
NCT01221311, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The current standard of care for benign bile duct strictures involves placement of multiple plastic stents under endoscopic and fluoroscopic guidance to progressively dilate or stretch it open. This approach necessitates multiple procedures which may extend over one year before the stricture is adequately dilated. The investigators propose a study comparing the standard approach of plastic stenting with the use of newer, fully coated metallic stents which are self-expandable, thereby permitting successful dilation of benign bile duct strictures with fewer procedures.
Interventions
- DEVICE Fully covered Metallic Stent
- DEVICE Plastic Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01221311
The ClinicalTrials.gov registry entry for NCT01221311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fully covered Metallic Stent is the first listed.
NCT01221311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01221311 about?
NCT01221311 is a clinical study titled "Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures". The current standard of care for benign bile duct strictures involves placement of multiple plastic stents under endoscopic and fluoroscopic guidance to progressively dilate or stretch it open. This approach necessitates multiple procedures which may extend over one year before the stricture is adeq...
What is the current status of trial NCT01221311?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2011-01. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01221311?
The interventions under investigation include: Fully covered Metallic Stent (DEVICE), Plastic Stent (DEVICE).
Who is sponsoring clinical trial NCT01221311?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.